These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27792859)

  • 1. Emerging cellular and gene therapies for congenital anemias.
    Ludwig LS; Khajuria RK; Sankaran VG
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):332-348. PubMed ID: 27792859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
    Anurogo D; Yuli Prasetyo Budi N; Thi Ngo MH; Huang YH; Pawitan JA
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders.
    Rao I; Crisafulli L; Paulis M; Ficara F
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promise of gene therapy to treat sickle cell disease.
    Romero Z; DeWitt M; Walters MC
    Expert Opin Biol Ther; 2018 Nov; 18(11):1123-1136. PubMed ID: 30324810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
    Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
    Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing in pluripotent stem cells: research and therapeutic applications.
    Deleidi M; Yu C
    Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward RNA Repair of Diamond Blackfan Anemia Hematopoietic Stem Cells.
    D'Allard DL; Liu JM
    Hum Gene Ther; 2016 Oct; 27(10):792-801. PubMed ID: 27550323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy for β-Hemoglobinopathies.
    Cavazzana M; Antoniani C; Miccio A
    Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cell based gene therapy for hematological diseases.
    Vanhee S; Vandekerckhove B
    Crit Rev Oncol Hematol; 2016 Jan; 97():238-46. PubMed ID: 26381313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular therapy for sickle cell disease.
    Abraham A; Jacobsohn DA; Bollard CM
    Cytotherapy; 2016 Nov; 18(11):1360-1369. PubMed ID: 27421743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential of hematopoietic stem cells as the basis for generation of advanced therapy medicinal products].
    Bönig H; Heiden M; Schüttrumpf J; Müller MM; Seifried E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):791-6. PubMed ID: 21698530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases?
    Tolosa L; Pareja E; Gómez-Lechón MJ
    Transplantation; 2016 Dec; 100(12):2548-2557. PubMed ID: 27495745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier.
    Papapetrou EP
    Adv Exp Med Biol; 2017; 1013():219-240. PubMed ID: 29127683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia: progress in molecular mechanisms and therapies.
    Sankaran VG; Weiss MJ
    Nat Med; 2015 Mar; 21(3):221-30. PubMed ID: 25742458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.